![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Malignant Lymphoma |
Free Subscription
1 Am J Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Induction of Transcriptional Inhibitor Hairy and Enhancer of Split Homolog-1 and
the Related Repression of Tumor-Suppressor Thioredoxin-Interacting Protein Are
Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase
Nucleophosm
Am J Pathol. 2022 May 28. pii: S0002-9440(22)00148.
PubMed
Abstract available
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in
relapsed/refractory follicular lymphoma.
Blood. 2022 Jun 9. pii: 485518. doi: 10.1182/blood.2021014375.
PubMed
Abstract available
Extranodal natural killer/T-cell lymphoma of the palate.
Blood. 2022;139:3450.
PubMed
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with
poor outcomes.
Blood. 2022;139:3303-3313.
PubMed
Abstract available
Granulomatous slack skin: clinical characteristics, prognosis, and response to
therapy. A study from the Cutaneous Lymphoma French Study Group.
Br J Dermatol. 2022 Jun 6. doi: 10.1111/bjd.21699.
PubMed
Mogamulizumab induces long-term immune restoration and reshapes tumour
heterogeneity in Sezary syndrome.
Br J Dermatol. 2022;186:1010-1025.
PubMed
Abstract available
PET-imaging assessment for guiding strategy in patients with relapsed/refractory
large B-cell lymphoma receiving CAR T-cells.
Haematologica. 2022 Jun 9. doi: 10.3324/haematol.2021.280550.
PubMed
Abstract available
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell
Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
J Clin Oncol. 2022 Jun 4:JCO2102370. doi: 10.1200/JCO.21.02370.
PubMed
Abstract available
Durable remissions in two adult patients with Burkitt lymphoma following
anti-CD19 CAR T-cell therapy: a single center experience.
Leuk Lymphoma. 2022 Jun 9:1-5. doi: 10.1080/10428194.2022.2076853.
PubMed
Mitigation strategies among cutaneous T-cell lymphoma patients with positive
Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the
risk of subsequent bacteremia.
Leuk Lymphoma. 2022 Jun 7:1-8. doi: 10.1080/10428194.2022.2081324.
PubMed
Abstract available
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
N Engl J Med. 2022 Jun 3. doi: 10.1056/NEJMoa2201817.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by